This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
HL - 155
Hodgkin Lymphoma (HL)
LOW-DOSE NIVOLUMAB COMBINED WITH AVD CHEMOTHERAPY (NIVO40-AVD) FOR ADVANCED-STAGE HODGKIN LYMPHOMA: INTERIM RESULTS OF A PHASE 2 TRIAL